Tilisolol

Drug Profile

Tilisolol

Alternative Names: Daim; N 696; Selecal

Latest Information Update: 14 Jul 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Nisshin Pharma
  • Developer Maruho; Nisshin Pharma; Toyama Chemical
  • Class Antiarrhythmics; Antihypertensives; Ischaemic heart disorder therapies; Isoquinolines
  • Mechanism of Action Beta-adrenergic receptor antagonists; Potassium channel agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Angina pectoris; Hypertension
  • Discontinued Arrhythmias; Glaucoma

Most Recent Events

  • 01 Jul 2008 Toyama Chemical has been acquired by FUJIFILM Holdings Corporation
  • 11 Sep 2000 Discontinued-Preclinical for Glaucoma in Japan (Ophthalmic)
  • 20 May 1997 No-Development-Reported for Glaucoma in Japan (Ophthalmic)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top